Overview PT-141 (Bremelanotide) is a synthetic peptide analog used in laboratory studies involving melanocortin receptor pathways.
Research Focus Researchers evaluate PT-141 to study MC3R and MC4R receptor signaling, intracellular pathway activation, and melanocortin system interactions.
Mechanism of Interest Its receptor-agonist activity provides a controlled model for studying signaling cascades associated with the central melanocortin pathways.
Compliance Notice For research only. Not for human consumption.

